Study: Melatonin agonist may reduce delirium in elderly patients

02/20/2014 | Medscape (free registration)

Elderly hospital patients given the melatonin agonist drug ramelteon at night had a lower risk of developing delirium, University of Amsterdam researchers reported in JAMA Psychiatry. An editorial, also from researchers at the University of Amsterdam, noted it is the first study to show a "significant prophylactic effect" on delirium in elderly ICU patients given the drug.

View Full Article in:

Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA